Application Note: Cardiac-Specific Toxicity – Real-Time Monitoring of Adverse Effects on Cardiomyocytes Derived from Embryonic Stem Cells
22 June 2015

This application note demonstrates how Cor.At® cardiomyocyte technology can produce physiologically relevant data for candidate substances in cardiac research.